MicroStrategy
MSTR
Ecopetrol
EC
MARA Holdings
MARA
Coinbase
COIN
Meta Platforms
META
US Stock MarketDetailed Quotes
GYRE Gyre Therapeutics
- 10.500
- -0.200-1.87%
Trading Jan 23 15:25 ET
901.13MMarket Cap-7.19P/E (TTM)
10.740High10.410Low46.13KVolume10.650Open10.700Pre Close485.05KTurnover0.29%Turnover RatioLossP/E (Static)85.82MShares26.37052wk High14.27P/B168.66MFloat Cap8.26052wk Low--Dividend TTM16.06MShs Float5798.166Historical High--Div YieldTTM3.08%Amplitude0.854Historical Low10.515Avg Price1Lot Size
Gyre Therapeutics Key Stats
EPS
According to the latest financial report of Gyre Therapeutics, the latest earnings per share (TTM) for the company is 0.01. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Gyre Therapeutics's free cash flow? The latest report shows it as 1.03M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Gyre Therapeutics shows that the company's current ratio is 3.72, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Gyre Therapeutics, the quick ratio is 3.12, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Gyre Therapeutics? The latest ROE figure is 1.82%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Gyre Therapeutics, the total asset return on investment (ROA) is 0.91%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Gyre Therapeutics's latest financial report to see how their gross margin is doing - currently at 96.24%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Gyre Therapeutics, the net profit margin is 11.21%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.